268 related articles for article (PubMed ID: 2058872)
21. Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy.
Custro N; Montalto G; Scafidi V; Soresi M; Gallo S; Tripi S; Notarbartolo A
J Endocrinol Invest; 1997; 20(7):374-80. PubMed ID: 9309534
[TBL] [Abstract][Full Text] [Related]
22. Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon.
Burman P; Tötterman TH; Oberg K; Karlsson FA
J Clin Endocrinol Metab; 1986 Nov; 63(5):1086-90. PubMed ID: 2944910
[TBL] [Abstract][Full Text] [Related]
23. Thyroid autoantibodies and thyroid dysfunction during treatment with interferon-alpha for chronic hepatitis C.
Kiehne K; Kloehn S; Hinrichsen H; Gallwitz B; Mönig H
Endocrine; 1997 Jun; 6(3):231-4. PubMed ID: 9368677
[TBL] [Abstract][Full Text] [Related]
24. Interferon-alpha and autoimmune thyroid disease.
Prummel MF; Laurberg P
Thyroid; 2003 Jun; 13(6):547-51. PubMed ID: 12930598
[TBL] [Abstract][Full Text] [Related]
25. Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour.
Rönnblom LE; Alm GV; Oberg KE
J Intern Med; 1990 Mar; 227(3):207-10. PubMed ID: 1690258
[TBL] [Abstract][Full Text] [Related]
26. Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested?
Välimäki M; Järvinen H; Salmela P; Sane T; Sjöblom SM; Pelkonen R
Cancer; 1991 Feb; 67(3):547-9. PubMed ID: 1702352
[TBL] [Abstract][Full Text] [Related]
27. [Autoimmune thyroid disease induced by interferon therapy].
Murakami M; Kakizaki S; Takayama H; Takagi H; Mori M
Nihon Rinsho; 1999 Aug; 57(8):1779-83. PubMed ID: 10483250
[TBL] [Abstract][Full Text] [Related]
28. [Occurrence and significance of autoantibodies in the course of interferon therapy of chronic hepatitis C].
Heller J; Musiolik J; Homrighausen A; Sauerbruch T; Spengler U
Dtsch Med Wochenschr; 1996 Sep; 121(39):1179-83. PubMed ID: 8925742
[TBL] [Abstract][Full Text] [Related]
29. Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.
Betterle C; Fabris P; Zanchetta R; Pedini B; Tositti G; Bosi E; de Lalla F
Diabetes Care; 2000 Aug; 23(8):1177-81. PubMed ID: 10937518
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study.
Obołończyk Ł; Siekierska-Hellmann M; Wiśniewski P; Lewczuk A; Berendt-Obołończyk M; Lakomy A; Michalska Z; Radowska D; Moszkowska G; Bianek-Bodzak A; Sworczak K
Postepy Hig Med Dosw (Online); 2017 Sep; 71(0):842-849. PubMed ID: 29039351
[TBL] [Abstract][Full Text] [Related]
31. Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha.
Gisslinger H; Gilly B; Woloszczuk W; Mayr WR; Havelec L; Linkesch W; Weissel M
Clin Exp Immunol; 1992 Dec; 90(3):363-7. PubMed ID: 1458673
[TBL] [Abstract][Full Text] [Related]
32. Development of transient thyroid disease and reaction during treatment of chronic hepatitis C with interferon.
Kodama T; Katabami S; Kamijo K; Katanuma A; Yamashita K; Azuma N; Tamaki T; Yachi A
J Gastroenterol; 1994 Jun; 29(3):289-92. PubMed ID: 8061797
[TBL] [Abstract][Full Text] [Related]
33. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
[TBL] [Abstract][Full Text] [Related]
34. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
35. Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon.
Kälkner KM; Rönnblom L; Karlsson Parra AK; Bengtsson M; Olsson Y; Oberg K
QJM; 1998 Jun; 91(6):393-9. PubMed ID: 9709457
[TBL] [Abstract][Full Text] [Related]
36. Low-titre auto-antibodies predict autoimmune disease during interferon-alpha treatment of chronic hepatitis C.
Bell TM; Bansal AS; Shorthouse C; Sandford N; Powell EE
J Gastroenterol Hepatol; 1999 May; 14(5):419-22. PubMed ID: 10355504
[TBL] [Abstract][Full Text] [Related]
37. Thyroid function and autoimmunity during interferon beta-1b treatment: a multicenter prospective study.
Durelli L; Ferrero B; Oggero A; Verdun E; Ghezzi A; Montanari E; Zaffaroni M;
J Clin Endocrinol Metab; 2001 Aug; 86(8):3525-32. PubMed ID: 11502774
[TBL] [Abstract][Full Text] [Related]
38. The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy.
Huang JF; Chuang WL; Dai CY; Chen SC; Lin ZY; Lee LP; Lee PL; Wang LY; Hsieh MY; Chang WY; Yu ML
J Viral Hepat; 2006 Jun; 13(6):396-401. PubMed ID: 16842442
[TBL] [Abstract][Full Text] [Related]
39. [Cytokine therapy and the endocrine system: is it necessary to monitor more than the thyroid gland?].
Schuppert F; Müller-Kunert E; Stöcker W; Bokemeyer C; Schmoll HJ; von zur Mühlen A; Rambusch EG
Med Klin (Munich); 1996 Feb; 91(2):59-65. PubMed ID: 8850099
[TBL] [Abstract][Full Text] [Related]
40. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens.
Chiovato L; Latrofa F; Braverman LE; Pacini F; Capezzone M; Masserini L; Grasso L; Pinchera A
Ann Intern Med; 2003 Sep; 139(5 Pt 1):346-51. PubMed ID: 12965943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
